Blood Clotting Protein Linked To Rheumatoid Arthritis
Researchers at Cincinnati Children’s have issued the first study showing that a protein normally involved in blood clotting (fibrin), also plays an important role in the inflammatory response and development of rheumatoid arthritis. Inflammatory joint disease appears to be driven by the engagement of inflammatory cells with fibrin matrices through a specific integrin receptor, aMB2. [click link for full article]
MabThera(R) Virtual Clinic Gives Rheumatologists Real-Life Patient Insight
The MabThera Virtual Clinic - an exciting web-based resource - is a new initiative that provides physicians with key insights into the use of MabThera (rituximab), the first and only selective B cell therapy for the treatment of rheumatoid arthritis (RA). Using anonymised real-life cases of RA patients from around the world, the Virtual Clinic details the experiences of practicing rheumatologists prescribing MabThera. [click link for full article]
Lexicon Files Investigational New Drug Application For LX2931 As A Potential Treatment For Rheumatoid Arthritis
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for LX2931, an oral drug candidate for rheumatoid arthritis and other autoimmune conditions. [click link for full article]
